HEDESKOV Center For Regenerative Practice ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 6.3% 3.9% 0.9%  
Credit score (0-100)  0 0 36 50 87  
Credit rating  N/A N/A BBB BBB A  
Credit limit (kDKK)  0.0 0.0 -0.0 -0.0 976.3  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  0.0 0.0 -446 -341 1,707  
EBITDA  0.0 0.0 -923 -821 1,174  
EBIT  0.0 0.0 -923 -821 1,174  
Pre-tax profit (PTP)  0.0 0.0 -1,015.0 -1,111.2 1,134.2  
Net earnings  0.0 0.0 -1,015.0 -1,062.3 1,134.2  
Pre-tax profit without non-rec. items  0.0 0.0 -1,015 -1,111 1,134  

 
See the entire income statement

Balance sheet (kDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 6,361 9,488 21,566  
Shareholders equity total  0.0 0.0 -975 -2,037 13,271  
Interest-bearing liabilities  0.0 0.0 7,245 11,310 8,561  
Balance sheet total (assets)  0.0 0.0 6,955 9,769 23,782  

Net Debt  0.0 0.0 6,869 11,181 7,633  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  0.0 0.0 -446 -341 1,707  
Gross profit growth  0.0% 0.0% 0.0% 23.6% 0.0%  
Employees  0 0 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 6,955 9,769 23,782  
Balance sheet change%  0.0% 0.0% 0.0% 40.5% 143.4%  
Added value  0.0 0.0 -922.7 -820.5 1,174.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 6,361 3,126 12,078  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  0.0 0.0 -1.0 -2.0 1.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  0.0% 0.0% 206.7% 240.4% 68.8%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  0.0% 0.0% -11.6% -8.3% 6.6%  
ROI %  0.0% 0.0% -12.7% -8.8% 7.1%  
ROE %  0.0% 0.0% -14.6% -12.7% 9.8%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% -12.3% -17.3% 55.8%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -744.5% -1,362.6% 650.0%  
Gearing %  0.0% 0.0% -743.1% -555.2% 64.5%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 2.5% 3.1% 0.4%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 0.1 0.0 0.2  
Current Ratio  0.0 0.0 0.1 0.0 0.2  
Cash and cash equivalent  0.0 0.0 375.5 129.4 927.5  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  0.0 0.0 -7,336.2 -11,525.0 -8,295.3  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -923 -821 1,174  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -923 -821 1,174  
EBIT / employee  0 0 -923 -821 1,174  
Net earnings / employee  0 0 -1,015 -1,062 1,134